In a breakthrough in May 2017, scientist in Bengaluru had found a new molecule that can enhance the efficiency of the autophagy - our body's own housekeeping mechanism: A process where healthy cells clean up toxic proteins preventing them from aggregating and killing the cells - in brain cells, which can significantly reduce degeneration of brain cells, the cause of disease like Parkinson's.
The TOI had then reported that this was seen as a potential drug, and the scientists led by Ravi Manjithaya from the Molecular Biology and Genetics Unit (MBGU) at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) had initiated procedures to take it to the next level.
Now, Vipragen Bioscience, a Mysuru-based biotech company has collaborated with JNCASR to identify therapeutic candidates for Neurodegenerative diseases (ND) such as Alzheimer's, Parkinson's and Huntington's.
Source: Times of India, January 25, 2019.
Read more at: